Tag Archive | "Pfizer"

Pfizer creates breaking news with Allergan purchase

Tags: , , ,


US drugs giant Pfizer has sealed a deal to buy Botox-maker Allergan for $160bn (£106bn) in what is the biggest pharmaceuticals deal in history. Read the full story

Pfizer in asset purchase and option to acquire AM-Pharma

Tags: ,


Pfizer has acquired a minority equity interest in AM-Pharma and secured an exclusive option to acquire the remaining equity in the company. Read the full story

EMD Serono and Pfizer in co-promotion agreement for Xalkori

Tags: ,


EMD Serono has begun co-promoting Pfizer's anaplastic lymphoma kinase (ALK) inhibitor XALKORI (crizotinib) as part of its global strategic alliance with Pfizer. Read the full story

Pfizer in collaboration agreement for lupus study

Tags: ,


23andMe announced the launch of the Lupus Research Study in collaboration with Pfizer. Read the full story

More merger talks for Claris Lifesciences: Pfizer, Amneal, Novartis…

Tags: , , , ,


India-based CLARIS Lifesciences Ltd., which operates a generic sterile injectables business, has become the belle of the ball as multi-national companies such as Pfizer Inc., Amneal, Novartis AG and Indian companies such as Lupin and Cipla, are lining up to play the Read the full story

Pfizer and ADDF in Alzheimer’s disease pact

Tags: , ,


The Alzheimer's Drug Discovery Foundation (ADDF) and Pfizer's Centers for Therapeutic Innovation (CTI) announced a collaboration designed to advance the development of new small-molecule drugs for Alzheimer's disease and related dementias Read the full story

Pfizer enters into $17bn merger agreement with Hospira

Tags: , , , ,


Pfizer and Hospira have entered into a definitive merger agreement under which Pfizer will acquire Hospira, the world’s leading provider of injectable drugs and infusion technologies and a global leader in biosimilars, Read the full story

Pfizer terminates spinal muscular atrophy pact with Repligen

Tags: , , ,


Pfizer issued to Repligen a notice of termination for convenience under the License Agreement, dated December 28, 2012 Read the full story

Pfizer and HemoShear to develop predictive model for preclinical drug-induced vascular injury

Tags: , ,


HemoShear announced a multi-year platform collaboration with Pfizer Read the full story

Pfizer acquires Redvax, gains promising CMV vaccine candidate

Tags: , , ,


Pfizer has acquired a controlling interest in Redvax Read the full story